Investigating how environmental factors affect brain health and Alzheimer's disease.
Neurodevelopmental and neurodegenerative effects of environmental determinants: altering neural cellular populations impacting homeostatic functions and inflammatory response.
This study is looking at how things in our environment, like harmful substances, might affect the brain and contribute to Alzheimer's disease, with the hope of finding new ways to prevent or treat the condition for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11075805 on NIH RePORTER |
What this research studies
This research explores the impact of environmental factors on the development and progression of Alzheimer's disease (AD). It focuses on how exposure to toxic substances and gene-environment interactions can influence brain cell health and inflammatory responses. By studying the role of glial cells and specific nuclear receptors, the research aims to uncover mechanisms that contribute to neurodegeneration and identify potential modifiable risk factors. Patients may benefit from insights that could lead to new prevention strategies or treatments for AD.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease, particularly those with a family history or exposure to environmental toxins.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have any risk factors related to environmental exposures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting environmental risk factors.
How similar studies have performed: Previous research has shown promising results in understanding the role of environmental factors in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Fitz, Nicholas Francis — University of Pittsburgh at Pittsburgh
- Study coordinator: Fitz, Nicholas Francis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.